FutureChem Co Ltd

FutureChem's capital structure shows a debt-to-equity ratio of 0.17, indicating a relatively conservative leverage position compared to industry norms. However, the company's liquidity is strained, with negative cash and equivalents of -KRW 11.5 million and a free cash flow of -KRW 14.6 billion. The current ratio of 2.37 suggests short-term obligations are covered, but the negative operating cash flow of -KRW 2.4 billion raises concerns about cash generation. Profitability metrics are sharply negative, with a return on equity of -20.59% and a return on assets of -15.1%. These figures fall well below the industry median for medical equipment and radiopharmaceutical firms, which typically report positive ROE and ROA. The company's operating loss of KRW 8.3 billion and net loss of KRW 11.3 billion highlight a significant underperformance relative to peers. The company's revenue is concentrated in a single business segment focused on radiopharmaceuticals and imaging precursors, with no disclosed geographic diversification. This lack of segment or geographic diversification increases exposure to regulatory, demand, and supply chain risks in the Korean market. Growth prospects are mixed. Revenue for the latest period was KRW 18.7 billion, but no year-over-year growth rate is provided. The company's capital expenditure of -KRW 8.5 billion suggests a reduction in investment, which may signal a strategic shift or financial constraint. The outlook for the current fiscal year is uncertain, with no clear direction provided in the data. Risk factors include liquidity constraints and a negative net cash position after subtracting total debt. The company's dilution risk is currently low, with no difference between basic and diluted shares outstanding. However, the negative free cash flow and operating cash flow suggest potential future dilution pressure if the company requires additional capital. Recent filings and transcripts are not provided in the input data, so no specific events can be cited. However, the financial snapshot indicates a company in operational and financial distress, with significant losses and negative cash flows.